5.05
+4.55%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Savara
From its filings with the US Securities and Exchange Commission
Savara is based in Austin, Texas and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker SVRA. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 December 2020, it reported revenue of $257,000.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 25 Jun 2001
- Employees
- 70
- Website
- savarapharma.com ↗
- Head office
- 6836 BEE CAVE ROAD, AUSTIN, TX, 78746
- Incorporated in
- DE
- Classification
- Pharmaceutical Preparations
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Matthew PaulsChairman of the Board, Chief Executive Officer, since 2017$4.9m
- Mr. David LowranceChief Financial and Administrative Officer, Secretary$1.9m
- Mr. Robert LutzChief Operating Officer$1.9m
- Ms. Anne EricksonChief Business Officer
- Ms. Kate MccabeChief Legal Officer
- Mr. Braden ParkerChief Commercial Officer
- Dr. Raymond PrattChief Medical Officer$698,690
- Dr. Joseph MccrackenLead Independent Director$196,500
- Mr. Nevan ElamIndependent Director$191,500
- Mr. Richard HawkinsIndependent Director$183,000
- Mr. David RamsayIndependent Director$194,250
- Dr. Annigje van Es-JohanssonIndependent Director$189,500
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 43
- Environment
- 42
- Social
- 73
- Governance
- 15
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Savara Inc has a strong portfolio of innovative products that have gained recognition in the market.
- The company boasts a highly skilled and experienced management team, driving strategic decision making.
- Savara Inc benefits from strong relationships with key partners and distributors, enhancing their market reach.
Weaknesses
- Savara Inc currently operates in a highly competitive industry, facing challenges from established competitors.
- The company's dependence on a limited number of key suppliers poses a potential risk to the supply chain.
- Savara Inc's limited global presence restricts access to certain geographic markets and potential customers.
Opportunities
- The growing demand for respiratory therapeutic solutions presents a significant market opportunity for Savara Inc.
- Expanding into emerging markets can help the company tap into new customer segments and diversify their revenue streams.
- Advancements in technology offer the potential for developing and introducing more efficient products.
Threats
- Intense competition within the industry could pose challenges to Savara Inc's market share and profitability.
- Potential regulatory changes or compliance requirements may impact the company's operations and product development.
- Economic instability or fluctuations in currency exchange rates could affect Savara Inc's financial performance.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.